Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12559523 | Compositions comprising chemerin analogs and methods of use | 🖼🧊📄§ | 2026-02-24 | 2040-07-29 | 0 | 31 |
| 12559504 | Benzotriazole derivative | 🖼🧊📄§ | 2026-02-24 | 2040-05-29 | 0 | 31 |
| 12559569 | Methods of treating bleeding disorders by administration of chimeras comprising anti-von Willebrand factor antibodies and clotting factors | 🖼🧊📄§ | 2026-02-24 | 2042-12-20 | 0 | 31 |
| 12558385 | Lactobacillus plantarum compositions and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2039-06-13 | 0 | 31 |
| 12558424 | T cells having enhanced anti-tumor activity | 🖼🧊📄§ | 2026-02-24 | 2040-08-06 | 0 | 31 |
| 12559474 | Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same | 🖼🧊📄§ | 2026-02-24 | 2042-02-17 | 0 | 31 |
| 12558353 | Method of reducing pulmonary exacerbations in respiratory disease patients | 🖼🧊📄§ | 2026-02-24 | 2043-12-20 | 0 | 31 |
| 12558399 | Isocyclosporin A for topical treatment of ocular diseases | 🖼🧊📄§ | 2026-02-24 | 2042-12-22 | 0 | 31 |
| 12558407 | Compositions for treatment of diffuse intrinsic pontine glioma | 🖼🧊📄§ | 2026-02-24 | 2040-05-01 | 0 | 31 |
| 12559718 | Diagnostic methods for t cell therapy | 🖼🧊📄§ | 2026-02-24 | 2043-08-24 | 0 | 31 |
| 12559480 | Methods of treatment using phenyl indole allosteric inhibitors of P97 ATPase | 🖼🧊📄§ | 2026-02-24 | 2041-12-20 | 0 | 31 |
| 12558363 | Compositions for clinical complications associated to devices implanted in the urinary tract | 🖼🧊📄§ | 2026-02-24 | 2040-12-29 | 0 | 31 |
| 12559576 | CD20-PD1 binding molecules and methods of use thereof | 🖼🧊📄§ | 2026-02-24 | 2042-11-09 | 0 | 31 |
| 12559572 | Compositions and methods for treating IgE-mediated disorders | 🖼🧊📄§ | 2026-02-24 | 2042-12-22 | 0 | 31 |
| 12558350 | Compositions and methods for treatment | 🖼🧊📄§ | 2026-02-24 | 2042-07-27 | 0 | 31 |
| 12559723 | Platform for generating safe cell therapeutics | 🖼🧊📄§ | 2026-02-24 | 2042-12-15 | 0 | 31 |
| 12560596 | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy | 🖼🧊📄§ | 2026-02-24 | 2045-09-30 | 0 | 31 |
| 12559555 | Anti-LILRB4 antibodies and derivative products | 🖼🧊📄§ | 2026-02-24 | 2041-03-12 | 0 | 31 |
| 12559726 | Universal donor cells | 🖼🧊📄§ | 2026-02-24 | 2043-01-06 | 0 | 31 |
| 12559461 | Antibiotic adjuvant compounds | 🖼🧊📄§ | 2026-02-24 | 2041-04-19 | 0 | 31 |
| 12558421 | Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof | 🖼🧊📄§ | 2026-02-24 | 2043-05-23 | 0 | 31 |
| 12558376 | Tissue repair by activated cells | 🖼🧊📄§ | 2026-02-24 | 2039-08-29 | 0 | 31 |
| 12558375 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-02-24 | 2042-08-03 | 0 | 31 |
| 12558394 | Application of traditional Chinese medicine composition to preparation of medicine for treating or preventing coronavirus infection | 🖼🧊📄§ | 2026-02-24 | 2041-03-11 | 0 | 31 |
| 12559471 | 1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof | 🖼🧊📄§ | 2026-02-24 | 2042-10-20 | 0 | 31 |
| 12558344 | Composition for preventing or treating brain-nervous system diseases comprising rita or derivatives thereof | 🖼🧊📄§ | 2026-02-24 | 2042-06-03 | 0 | 31 |
| 12558351 | Compositions and methods for enhancing cancer immune checkpoint therapy | 🖼🧊📄§ | 2026-02-24 | 2040-03-20 | 0 | 31 |
| 12559719 | Engineered expression of cell surface and secreted sialidase by CAR T cells for increased efficacy in solid tumors | 🖼🧊📄§ | 2026-02-24 | 2044-03-29 | 0 | 31 |
| 12558352 | Use of malic enzyme 1 (ME1) in preparation of drug for preventing and treating pulmonary hypertension (PH) | 🖼🧊📄§ | 2026-02-24 | 2043-06-09 | 0 | 31 |
| 12558326 | Method for treating epilepsy | 🖼🧊📄§ | 2026-02-24 | 2039-07-26 | 0 | 31 |
| 12559574 | Use of succinate as biomarker in diagnosis and treatment of cancers | 🖼🧊📄§ | 2026-02-24 | 2040-10-16 | 0 | 31 |
| 12559458 | Co-crystals or salts of psilocin and methods of treatment therewith | 🖼🧊📄§ | 2026-02-24 | 2043-03-03 | 0 | 31 |
| 12559549 | Antibody binding to super-repressor IκB (srIκB) or antigen binding fragment thereof | 🖼🧊📄§ | 2026-02-24 | 2040-12-31 | 0 | 31 |
| 12558401 | Insulinotropic and glucagonotropic effects of beta-lactoglobulin | 🖼🧊📄§ | 2026-02-24 | 2040-11-20 | 0 | 31 |
| 12558339 | Composition comprising (7S)-(+)-cyclopentyl carbarmic acid, 8,8-dimethyl-2-oxo-6,7-dihydro-2H,8H-pyrano[3,2-g]chromen-7-yl-ester as active ingredient for prevention, alleviation, or treatment of eye disease | 🖼🧊📄§ | 2026-02-24 | 2042-01-05 | 0 | 31 |
| 12559496 | Imidazopyrimidines as modulators of IL-17 | 🖼🧊📄§ | 2026-02-24 | 2041-04-28 | 0 | 31 |
| 12558400 | Method of treatment of soft tissue sarcoma with a peptide comrpising a PCNA interacting motif | 🖼🧊📄§ | 2026-02-24 | 2041-04-27 | 0 | 31 |
| 12558340 | ANAVEX2-73 for the treatment of genetic neurodevelopmental disorders | 🖼🧊📄§ | 2026-02-24 | 2042-01-21 | 0 | 31 |
| 12551562 | Methods and compositions for irreversible enzyme inhibition | 🖼🧊📄§ | 2026-02-17 | 2040-04-10 | 0 | 31 |
| 12551474 | Use of pridopidine for the treatment of fragile X syndrome | 🖼🧊📄§ | 2026-02-17 | 2042-01-31 | 0 | 31 |
| 12551542 | Polymeric nanoparticles that target liver sinusoidal endothelial cells to induce antigen-specific immune tolerance | 🖼🧊📄§ | 2026-02-17 | 2040-11-11 | 0 | 31 |
| 12552779 | 1-alkyl-5-arylidene-2-selenoxoimidazolidine-4-on and derivative thereof, preparation method therefor, and composition comprising same for preventing, alleviating or treating neurodegenerative diseases | 🖼🧊📄§ | 2026-02-17 | 2041-07-09 | 0 | 31 |
| 12552871 | Nucleic acids encoding humanized anti-NGF antibodies | 🖼🧊📄§ | 2026-02-17 | 2041-03-12 | 0 | 31 |
| 12552865 | High affinity nanobodies targeting B7-H3 (CD276) for treating multiple solid tumors | 🖼🧊📄§ | 2026-02-17 | 2040-10-21 | 0 | 31 |
| 12552804 | Tricyclic heterocycles as FGFR inhibitors | 🖼🧊📄§ | 2026-02-17 | 2043-12-19 | 0 | 31 |
| 12553063 | CAS13 family AAV vectors and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2040-04-10 | 0 | 31 |
| 12551458 | Topical pharmaceutical composition containing phospholipids | 🖼🧊📄§ | 2026-02-17 | 2044-10-28 | 0 | 31 |
| 12552830 | Steroidal compound derivatives as therapeutic agents | 🖼🧊📄§ | 2026-02-17 | 2041-12-17 | 0 | 31 |
| 12552782 | Analogs of nitrofuran antibiotics to combat resistance | 🖼🧊📄§ | 2026-02-17 | 2043-01-17 | 0 | 31 |
| 12552778 | Analogs for the treatment of disease | 🖼🧊📄§ | 2026-02-17 | 2042-08-05 | 0 | 31 |